| 18 Apr, 11:57 am | — | … | Lupin Ltd - 500257 - U.S. FDA Has Concluded An Inspection At The Company''s Manufacturing Facility Located In Somerset, New Jersey, U.S.A. | bse |
| 17 Apr, 05:15 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Acquisition | bse |
| 17 Apr, 05:15 pm | — | … | Lupin Limited has informed the Exchange about Incorporation of a wholly owned subsidiary in Thailand. | nse |
| 17 Apr, 06:52 am | — | … | Lupin Limited has informed the Exchange about execution of Settlement Agreement. | nse |
| 10 Apr, 07:52 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 10 Apr, 07:49 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated April 10, 2026, titled "Lupin Launches Dapagliflozin Tablets in the United States". | nse |
| 08 Apr, 05:24 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 08 Apr, 05:20 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated April 08, 2026, titled "Lupin Announces Approval of Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in the United States ". | nse |
| 07 Apr, 09:26 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 07 Apr, 09:21 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated April 07, 2026, titled "Lupin Announces the Approval of Dapagliflozin Tablets in the United States". | nse |
| 07 Apr, 10:55 am | — | … | Lupin Limited has informed the Exchange regarding a press release dated April 07, 2026, titled "Lupin Earns Great Place To Work Certification for 2026-27". | nse |
| 07 Apr, 10:54 am | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 02 Apr, 10:58 am | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 02 Apr, 10:58 am | — | … | Lupin Limited has informed the Exchange regarding a press release dated April 02, 2026, titled "Lupin Completes Acquisition of VISUfarma". | nse |
| 01 Apr, 06:42 pm | — | … | Lupin Limited has informed the Exchange about signing of definitive agreement for Acquisition of minority shareholding in Multicare Pharmaceuticals Philippines, Inc., by Nanomi B.V., the Netherlands, a wholly owned subsidiary of the Company. | nse |
| 01 Apr, 05:26 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Updates on Acquisition | bse |
| 01 Apr, 05:24 pm | — | … | Lupin Limited has informed the Exchange about completion of the acquisition of entire share capital of VISUfarma B.V., Netherlands, by Nanomi B.V., the Netherlands, wholly owned subsidiary of the Company. | nse |
| 31 Mar, 08:32 am | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 31 Mar, 08:28 am | — | … | Lupin Limited has informed the Exchange regarding a press release dated March 31, 2026, titled "Lupin Receives Tentative Approval from U.S. FDA for Sugammadex Injection". | nse |
| 30 Mar, 09:40 am | — | … | Lupin Limited has informed the Exchange about Buyback of Shares by Multicare Pharmaceuticals Philippines, Inc., a subsidiary company. | nse |
| 25 Mar, 09:16 am | — | … | Lupin Limited has informed the Exchange regarding a press release dated March 25, 2026, titled "Lupin Receives Tentative Approval from U.S. FDA for Pitolisant Tablets". | nse |
| 25 Mar, 09:12 am | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 19 Mar, 08:15 am | — | … | Lupin Limited has informed the Exchange regarding a press release dated March 19, 2026, titled "Lupin Manufacturing Solutions Announces Expansion of Manufacturing Facility at Dabhasa, India". | nse |
| 19 Mar, 08:13 am | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 17 Mar, 12:08 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 17 Mar, 12:05 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated March 17, 2026, titled "Lupin and Zydus Sign Licensing Agreement for Co-marketing Innovative Semaglutide Injection in India". | nse |
| 07 Mar, 05:55 pm | — | … | Lupin Limited has informed the Exchange about U.S. FDA has concluded an inspection at our manufacturing facility at Ankleshwar, India. | nse |
| 02 Mar, 09:02 pm | — | … | Lupin Ltd - 500257 - Disclosure Pursuant To Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015. | bse |
| 02 Mar, 08:58 pm | — | … | Lupin Limited has informed the Exchange about General Updates. | nse |
| 27 Feb, 04:54 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Updates on Acquisition | bse |
| 27 Feb, 04:51 pm | — | … | Lupin Limited has informed the Exchange about further update on acquisition of VISUfarma B.V., the Netherlands. | nse |
| 27 Feb, 01:03 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 27 Feb, 01:00 pm | — | … | Lupin Limited has submitted a press release dated February 27, 2026, regarding receipt of Establishment Inspection Report (EIR) by the Company from the U.S. FDA for its facility in Goa, India. | nse |
| 26 Feb, 08:42 pm | — | … | Lupin Limited has informed the Exchange regarding a revised press release dated February 26, 2026, titled "Vinita Gupta, Lupin CEO, Named to the 2026 CNBC Changemakers List of Women Transforming Business for Making Medicines Accessible and Affordable for Americans". | nse |
| 26 Feb, 08:38 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised) | bse |
| 26 Feb, 08:02 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 26 Feb, 07:56 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated February 26, 2026, titled "Vinita Gupta, Lupin CEO, Named to the 2026 CNBC Changemakers List of Women Transforming Business for Making Medicines Accessible and Affordable for Americans". | nse |
| 26 Feb, 04:36 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 26 Feb, 04:34 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated February 26, 2026, titled "Lupin Ranks No. 1 Globally in Pharma; Tops All Sectors in India in S&P ESGAssessment 2025". | nse |
| 25 Feb, 04:52 pm | — | … | Lupin Ltd - 500257 - Disclosure Pursuant To Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 | bse |
| 25 Feb, 04:45 pm | — | … | Lupin Limited has informed the Exchange about General Updates. | nse |
| 24 Feb, 07:13 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated February 24, 2026, titled "Lupin Announces the Approval and Launch of Brivaracetam Oral Solution in the United States". | nse |
| 24 Feb, 07:11 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 23 Feb, 03:30 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 23 Feb, 03:27 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated February 23, 2026, titled "Lupin Receives European Commission Approval for Biosimilar Ranibizumab". | nse |
| 17 Feb, 05:21 pm | — | … | Lupin Limited has informed the Exchange about Transcript of Q3 FY2026 Earnings Conference Call. | nse |
| 17 Feb, 05:16 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 16 Feb, 04:00 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 16 Feb, 04:00 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated February 16, 2026, titled "Lupin Signs License and Supply Agreement with Spektus to Commercialize Novel Antidepressant DeslaFlex in Canada". | nse |
| 14 Feb, 11:12 am | — | … | Lupin Limited has informed the Exchange about Copy of Newspaper Publication in respect of Unaudited Financial Results of the Company for quarter and nine months ended December 31, 2025. | nse |